Joseph Folz, DO
Pain Medicine · Evansville, INNPI 1881013647
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,450 of the $5,410 with a category attached, or 82.3%. 29 manufacturers reported payments, led by Abbott at 53.1% of the total. Reporting peaked in 2019 at $1,568 and has fallen 70.3% since, to $466 in 2025.
Across 232 payments — averaging $23.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$3K
- AbbVie$859
- Amgen$492
- Vertos Medical, Inc.$130
- Nevro Corp.$112
- Biohaven Pharmaceutical Holding Company Ltd.$108
- plus $839 from 23 others
What the payments were for
- Travel & lodging$96018%
- Food & beverage$4,45082%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 104 | $2,871 |
| AbbVie(2 entities) | 42 | $859 |
| Amgen(2 entities) | 30 | $492 |
| Vertos Medical, Inc. | 3 | $130 |
| Nevro Corp. | 1 | $112 |
| Biohaven Pharmaceutical Holding Company Ltd. | 6 | $108 |
| Novartis | 6 | $108 |
| Avanos Medical | 1 | $77 |
| Biohaven Pharmaceuticals, Inc. | 5 | $68 |
| Pfizer | 4 | $55 |
| Collegium Pharmaceutical, Inc. | 3 | $53 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $50 |
| Medtronic(2 entities) | 3 | $50 |
| Lilly USA, LLC | 3 | $41 |
| Stryker | 1 | $41 |
| Bioventus LLC | 2 | $39 |
| Si-bone, Inc. | 1 | $32 |
| Arbor Pharmaceuticals, Inc. | 2 | $29 |
| Vertex | 1 | $28 |
| Scilex Pharmaceuticals Inc. | 2 | $27 |
| Almatica Pharma LLC | 1 | $20 |
| Ipsen Biopharmaceuticals, Inc | 1 | $20 |
| Tersera Therapeutics LLC | 1 | $19 |
| Spinal Simplicity, LLC | 1 | $15 |
| Ironshore Pharmaceuticals Inc. | 1 | $15 |
| MDD US Operations, LLC | 1 | $15 |
| Boston Scientific | 1 | $14 |
| Stimwave Technologies Incorporated | 1 | $14 |
| Teva Pharmaceuticals USA, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,410 in reported general payments places this provider in the 65th percentile of 128 pain medicine providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BelbucaBuprenorphine Hcl | 74 | $51,123 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 1,139 | $31,956 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 1,464 | $31,592 |
| Buprenorphine | 76 | $23,075 |
| OxycontinOxycodone Hcl | 24 | $20,086 |
| Fentanyl | 48 | $6,737 |
| Gabapentin | 499 | $6,143 |
| Pregabalin | 184 | $5,481 |
| Oxycodone Hcl | 193 | $5,303 |
| Hydromorphone Hcl | 131 | $2,772 |
| AmantadineAmantadine Hcl | 16 | $2,070 |
| Morphine Sulfate ErMorphine Sulfate | 54 | $1,868 |
| Lidocaine | 17 | $1,510 |
| Tramadol Hcl | 163 | $1,150 |
| Tizanidine Hcl | 123 | $887 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Belbuca | $53 | $51,12374 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 128 pain medicine providers in Indiana.
Other pain medicine in Evansville
- Nicolaus WintersEvansville$9K
- Francis McDonnellEvansville$6K
- David JohnsonEvansville$4K
- Katherine WilliamsEvansville$4K
- Derron WilsonCarmel$616K
- Kevin MacadaegCarmel$337K
- Andrew TrobridgeMuncie$253K
- Meredith LanghorstFishers$233K
- Abhishek DasMishawaka$186K
- Rajiv TewariFishers$140K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.